TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Tataa Biocenter AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
37,860
|
52,839
|
34,738 |
| Financial expenses |
1
|
7
|
340 |
| Earnings before taxes |
-51,461
|
-61,144
|
-57,234 |
| EBITDA |
-46,373
|
-55,233
|
-51,543 |
| Total assets |
37,314
|
44,370
|
41,941 |
| Current assets |
24,769
|
27,131
|
21,441 |
| Current liabilities |
17,153
|
14,481
|
25,162 |
| Equity capital |
20,162
|
29,888
|
16,779 |
| - share capital |
143
|
141
|
131 |
| Employees (average) |
41
|
46
|
47 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
54.0%
|
67.4%
|
40.0% |
| Turnover per employee |
923
|
1,149
|
739 |
| Profit as a percentage of turnover |
-135.9%
|
-115.7%
|
-164.8% |
| Return on assets (ROA) |
-137.9%
|
-137.8%
|
-135.7% |
| Current ratio |
144.4%
|
187.4%
|
85.2% |
| Return on equity (ROE) |
-255.2%
|
-204.6%
|
-341.1% |
| Change turnover |
-15,931
|
15,636
|
-54,378 |
| Change turnover % |
-30%
|
42%
|
-61% |
| Chg. No. of employees |
-5
|
-1
|
6 |
| Chg. No. of employees % |
-11%
|
-2%
|
15% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.